STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
· statnews.com · popularity 33/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at statnews.com →
Summary
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 5.